ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,466Medicare Part D Prescriptions Filled, Including Refills

Rank: 182 out of 1692

$466K Total Retail Price of All Prescriptions

Rank: 283 out of 1692

458 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 435 328 1 7
LISINOPRIL 425 301 2 2
SIMVASTATIN 411 316 3 1
OMEPRAZOLE 393 275 4 5
LEVOTHYROXINE SODIUM 360 294 5 4
AMLODIPINE BESYLATE 343 271 6 3
METOPROLOL TARTRATE 299 224 7 10
HYDROCHLOROTHIAZIDE 264 200 8 9
HYDROCODONE-ACETAMINOPHEN 264 231 S3 8 6
METFORMIN HCL 260 176 10 8
TRAMADOL HCL 223 168 11 16
WARFARIN SODIUM 172 120 12 14
POTASSIUM CHLORIDE 160 133 13 20
GABAPENTIN 160 95 13 13
SPIRIVA 150 117 15 44
PROAIR HFA 141 69 16 40
LOVASTATIN 136 101 17 37
GLIPIZIDE 126 89 18 47
ATORVASTATIN CALCIUM 123 90 19 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 98 20 19
ATENOLOL 116 105 21 15
TAMSULOSIN HCL 109 99 22 31
ALLOPURINOL 102 98 23 30
MELOXICAM 100 70 24 41
CLOPIDOGREL 99 68 25 43
PRAVASTATIN SODIUM 91 67 26 12
PREDNISONE 86 67 27 35
LOSARTAN POTASSIUM 84 70 28 17
CARVEDILOL 79 57 29 24
RANITIDINE HCL 78 49 30 28
METOPROLOL SUCCINATE 77 58 31 18
FLUTICASONE PROPIONATE 76 46 32 27
CITALOPRAM HBR 74 50 33 21
AZITHROMYCIN 73 55 34 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 48 34 100
GLYBURIDE 70 52 R 36 82
NEXIUM 70 43 36 25
FAMOTIDINE 68 31 38 86
PLAVIX 67 49 39 66
AMITRIPTYLINE HCL 66 35 R 40 58
GLIPIZIDE ER 66 66 40 87
PAROXETINE HCL 66 47 40 60
ISOSORBIDE MONONITRATE ER 64 53 43 55
QUINAPRIL HCL 64 52 43 147
FINASTERIDE 63 63 45 99
ENALAPRIL MALEATE 61 37 46 71
NAPROXEN 61 44 46 91
ADVAIR DISKUS 58 32 48 45
ACTOS 54 39 49 117
SPIRONOLACTONE 53 51 50 74
TRIAMCINOLONE ACETONIDE 50 37 51 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.